The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Chemoimmunotherapy combination after PD-1 inhibitor failure to improve clinical outcomes in metastatic melanoma patients.
 
Jesus Vera Aguilera
No Relationships to Disclose
 
Jonas Paludo
No Relationships to Disclose
 
Anagha Bangalore
No Relationships to Disclose
 
Jarrett Failing
No Relationships to Disclose
 
Robert R. McWilliams
Consulting or Advisory Role - Merrimack (Inst)
Research Funding - Aduro Biotech (Inst); Genentech (Inst); Lilly (Inst); Newlink Genetics (Inst); Novartis (Inst); Pfizer (Inst); PRISM BioLab (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Lisa A. Kottschade
Consulting or Advisory Role - Merck (Inst); Novartis
 
Matthew Stephen Block
Research Funding - Genentech/Roche; Immune Design; Merck; TapImmune Inc.
 
Svetomir Markovic
Research Funding - Celgene; Seagen
 
Roxana Stefania Dronca
Research Funding - Merck Sharp & Dohme (Inst)
Other Relationship - Elsevier
 
Yiyi Yan
No Relationships to Disclose